STA Pharma, Regulus team up for mRNA targeting drugs

A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...

February 23, 2018 | Friday | News
Asia needs a legal framework to combat rare diseases

Orphan diseases, once rare, are now affecting larger populations, with one in every 5000 people suffering from a rare ge...

February 8, 2018 | Thursday | Analysis
DL Medicine teams up with Pfizer for new drug discovery

China based biotechnology company NetVation DL Medicine has entered into a two-year research collaboration with Pfizer I...

February 7, 2018 | Wednesday | News
New study shows baldness and prostate cancer may be interrelated

Singapore - A recent study observed a connection between male-pattern baldness, when it occurs at a young age, and the s...

January 25, 2018 | Thursday | News
XtalPi secures $15 M funding

Computation-driven pharmaceutical technology company XtalPi Inc. has closed a Series B funding round of $15 million led ...

January 24, 2018 | Wednesday | News
OBI Pharma receives FDA nod for Phase I study of its cancer drug

Taiwan-based biopharma company OBI Pharma announced that it has received the US FDA nod for an investigational new drug ...

January 18, 2018 | Thursday | News
Forty Seven collaborates with Merck KGaA on a novel combination for ovarian cancer

Singapore - Forty Seven, a US based clinical-stage company focused on developing the next generation of transformational...

January 16, 2018 | Tuesday | News
FDA approves first treatment for breast cancer with a certain inherited genetic mutation

Singapore - The U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include th...

January 15, 2018 | Monday | News
Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives

Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...

January 15, 2018 | Monday | News
BerGenBio meets first efficacy endpoint in phase II trial evaluating BGB324

A clinical –stage biopharmaceutical company BerGenBio ASA has announced that the first efficacy endpoint has been ...

January 10, 2018 | Wednesday | News
Intec Pharma acknowledged with patent

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordio...

January 8, 2018 | Monday | Regulatory
Pfizer to launch a new venture fund to invest in neuroscience research projects

The U.S. pharmaceutical company, Pfizer has announced that it is abandoning research to find new drugs aimed at treating...

January 8, 2018 | Monday | News
Drug for diabetes type 2 shows potential in treating Alzheimer’s

According to new research published in the Brain Research Journal, a drug developed for type 2 diabetes could possibly b...

January 4, 2018 | Thursday | News
Biocon & Mylan's biosimilar gets Brazilian approval

The biosimilar trastuzumab has been approved by ANVISA, the Brazilian regulatory agency. Co-developed by Biocon and...

December 29, 2017 | Friday | News
FDA approves drug to treat dangerously low blood pressure

Singapore - The U.S. Food and Drug Administration approved Giapreza (angiotensin II) injection for intravenous infusion ...

December 27, 2017 | Wednesday | News
Dr. Reddy's launches Melphalan Hydrochloride for Injection in the U.S. Market

Dr. Reddy’s Laboratories Ltd has announced that it has launched Melphalan Hydrochloride for Injection which is a t...

December 27, 2017 | Wednesday | News
CANbridge submits investigational new drug application for cancer treatment

CANbridge Life Sciences is a bio-pharmaceutical company accelerating development and commercialization of specialty heal...

December 27, 2017 | Wednesday | News
Otsuka collaborates with X-Chem for new drug compounds

US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in To...

December 26, 2017 | Tuesday | News